Birchview Capital, LP Portfolio Holdings

Birchview Capital, LP

  • $124 Million
  • Q3 2025

Birchview Capital, LP has filed its 13F form on November 13, 2025 for Q3 2025 where it was disclosed a total value porftolio of $124 Million distributed in 69 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Kla Corp with a value of $23.6M, Bristol Myers Squibb CO with a value of $14.3M, Corcept Therapeutics Inc with a value of $5.58M, Prothena Corp Public LTD CO with a value of $5.36M, and Stoke Therapeutics, Inc. with a value of $4.94M.

Examining the 13F form we can see an increase of $29M in the current position value, from $95M to 124M.

Birchview Capital, LP is based out at Burlington, VT

Below you can find more details about Birchview Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $124 Million
Healthcare: $93.3 Million
Technology: $23.6 Million
Energy: $6.22 Million
Basic Materials: $707,000
ETFs: $208,000

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$0
$208,000 0.17% of portfolio
1,498
Q3 2025 New

Summary

  • Portfolio
  • No. of Stocks 69
  • Current Value $124 Million
  • Prior Value $95 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 13, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 8 stocks
  • Additional Purchases 18 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 14 stocks
Track This Portfolio

Track Birchview Capital, LP Portfolio

Follow Birchview Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birchview Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email